XASXONE
Market cap126mUSD
Dec 19, Last price
0.30AUD
1D
-1.64%
1Q
-9.09%
Jan 2017
-95.28%
IPO
-92.17%
Name
Oneview Healthcare PLC
Chart & Performance
Profile
Oneview Healthcare PLC develops and sells software and related consultancy services for the healthcare sector in Ireland, the United States, Australia, Asia, and the Middle East. The company operates Care Experience Platform (CXP) Cloud Start that allows customers to implement critical digital engagement capabilities across their entire enterprise; CXP Cloud Enterprise, which gives patients and their families the ability to communicate virtually with healthcare teams along with access to education and health information; and CXP Enterprise On-Prem that meets enterprise needs across various types of facilities from new construction to existing hospitals with legacy wiring. It also provides empower patients and families, manage patient experience, deliver virtual care, digital door sign, and patient communication board solutions. The company was founded in 2008 and is based in Dublin, Ireland.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 9,397 5.33% | 8,921 -8.33% | 9,732 37.03% | ||||||
Cost of revenue | 9,429 | 25,980 | 20,730 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | (32) | (17,058) | (10,998) | ||||||
NOPBT Margin | |||||||||
Operating Taxes | 50 | (55) | 57 | ||||||
Tax Rate | |||||||||
NOPAT | (81) | (17,003) | (11,055) | ||||||
Net income | (8,935) -17.80% | (10,869) 32.80% | (8,185) -13.43% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 13,291 | 218 | 12,506 | ||||||
BB yield | -9.41% | -0.38% | -10.94% | ||||||
Debt | |||||||||
Debt current | 153 | 172 | 367 | ||||||
Long-term debt | 1,718 | 914 | 2,043 | ||||||
Deferred revenue | 12 | 20 | 55 | ||||||
Other long-term liabilities | 247 | 2,790 | |||||||
Net debt | (9,678) | (5,324) | (12,767) | ||||||
Cash flow | |||||||||
Cash from operating activities | (11,766) | (10,196) | (4,027) | ||||||
CAPEX | (192) | (45) | (65) | ||||||
Cash from investing activities | (849) | (45) | (65) | ||||||
Cash from financing activities | 13,037 | (100) | 12,219 | ||||||
FCF | (505) | (16,334) | (10,688) | ||||||
Balance | |||||||||
Cash | 11,549 | 6,410 | 15,176 | ||||||
Long term investments | |||||||||
Excess cash | 11,079 | 5,964 | 14,689 | ||||||
Stockholders' equity | 9,140 | 2,257 | 9,900 | ||||||
Invested Capital | 1,195 | 3,353 | 1,194 | ||||||
ROIC | |||||||||
ROCE | |||||||||
EV | |||||||||
Common stock shares outstanding | 588,669 | 522,320 | 431,345 | ||||||
Price | 0.24 118.18% | 0.11 -58.49% | 0.27 488.89% | ||||||
Market cap | 141,281 145.90% | 57,455 -49.74% | 114,306 1,263.84% | ||||||
EV | 131,602 | 52,131 | 101,540 | ||||||
EBITDA | (32) | (16,385) | (9,927) | ||||||
EV/EBITDA | |||||||||
Interest | 517 | 162 | 119 | ||||||
Interest/NOPBT |